New website launched
Brentwood, 13 September 2011 Martindale Pharma® today announces the launch of their new corporate website.
Online improvements to match the lofty ambitions of Martindale Pharma®
Brentwood, 13 September 2011: Martindale Pharma®, leaders in the manufacture and supply of specialty pharmaceuticals and services, announces that its new and much improved corporate website is launched today and includes the ability for customers to place orders for Martindale Pharma Specials on-line.
The future looks bright for the UK’s number one specials manufacturer Martindale Pharma®. This is reflected in their brand new corporate website, which is now up and running. The need for a new Martindale Pharma® website was not just about creating a brighter clearer design that’s easier to read, it’s been built to be far more useful and user-friendly. Clear improvements include a regularly updated news page, an email enquiry form, comprehensive Specials listings with product search option, as well as a robust online ordering system.
“Our new website is far more ‘client focused’ and reflects our growing reputation across the five business segments we operate in; Addictions, Specials, Hospital Specialty Products, Ophthalmics and Critical Care.” Says Richard de Souza, Chief Executive Officer. “As we extend our reach around the globe, it’s crucial that our online service effectively communicates who we are and what we can do for our clients, as well as providing a 24/7 resource.”
The new look website is available for review at www.martindalepharma.co.uk.
Existing Martindale Pharma® account holder can also register for online ordering.
Notes to editors:
After starting out as a London chemist store owned by William Martindale, Martindale Pharma has remained in business for more than a century and is now firmly established as a leading supplier to the UK’s NHS and exports its products to a number of other major pharmaceutical markets.
In May 2010 AAC Capital bought Martindale Pharma from Cardinal Health. AAC Capital continues to develop the business and pursue growth opportunities.
Martindale Pharma manufacture the majority of their product‟s at their own facilities in the UK, in total producing and packing c.50 million doses a year in a range of formats including sterile ampoules/vials, oral solutions, pre-filled syringes, suppositories and ophthalmics.
Martindale Pharma’s key business segments are:
For further information visit martindalepharma.co.uk
Media contacts:
Martindale Pharma
Michael Clark
Tel: +44 (0) 1277 235313
M:Communications
Mary Clark / Amber Bielecka
Tel : +44 (0) 207 920 2361